Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

[This corrects the article DOI: 10.1371/journal.pone.0171356.].

Bibliographic Details
Main Author: PLOS ONE Staff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5354437?pdf=render
id doaj-8c3b555804f84d38b4cd21449b2d7196
record_format Article
spelling doaj-8c3b555804f84d38b4cd21449b2d71962020-11-25T02:33:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017449310.1371/journal.pone.0174493Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.PLOS ONE Staff[This corrects the article DOI: 10.1371/journal.pone.0171356.].http://europepmc.org/articles/PMC5354437?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author PLOS ONE Staff
spellingShingle PLOS ONE Staff
Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
PLoS ONE
author_facet PLOS ONE Staff
author_sort PLOS ONE Staff
title Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
title_short Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
title_full Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
title_fullStr Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
title_full_unstemmed Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
title_sort correction: yes1 signaling mediates the resistance to trastuzumab/lap atinib in breast cancer.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description [This corrects the article DOI: 10.1371/journal.pone.0171356.].
url http://europepmc.org/articles/PMC5354437?pdf=render
work_keys_str_mv AT plosonestaff correctionyes1signalingmediatestheresistancetotrastuzumablapatinibinbreastcancer
_version_ 1724812326514720768